Electrosurgical tissue and vessel sealing device

Information

  • Patent Grant
  • 10912602
  • Patent Number
    10,912,602
  • Date Filed
    Friday, November 3, 2017
    7 years ago
  • Date Issued
    Tuesday, February 9, 2021
    3 years ago
Abstract
An electrosurgical device can be delivered to a tissue site to provide supplemental sealing of vessels and/or vascular tissue that include suturing, stapling, or the like. The electrosurgical device is generally in the form of forceps, and includes an end effector assembly including opposing movable jaws. Each jaw includes a deformable pad or cushion including an electrode array positioned thereon. Each deformable cushion is configured to deliver a fluid, such as saline, during activation of the electrode array, thereby creating a virtual electrode which couples radiofrequency (RF) energy emitted from the electrode array into tissue in which the RF energy is converted into thermal energy. The deformable cushion and electrode array provide a controlled degree of compression upon the target tissue or vessel to maintain integrity of a suture, staple, or clip, as well as controlled energy emission for sealing, cauterizing, coagulating, and/or desiccating the target tissue or vessel.
Description
FIELD

The present disclosure relates generally to medical devices for sealing tissue, and, more particularly, to an electrosurgical device in the form of forceps including an end effector assembly including opposing jaws for providing controlled compression and energy emission for sealing, cauterizing, coagulating, and/or desiccating vessels and vascular tissue including been previously sutured or stapled.


BACKGROUND

Most surgical procedures require some form of closure of a vessel, wound, or incision. For example, in many procedures, a surgeon will rely on sutures as a means of surgically occluding a vessel, closing wounds, as well as coupling portions of tissue to one another (e.g., bypass surgeries and anastomoses formation). More recently, surgical staples and clips have become commonly used in place of sutures, where appropriate, as stapling can be much faster than suturing by hand, and can also be more accurate and consistent. Furthermore, stapling may not require the degree of experience and expertise that suturing generally requires. Staples may primarily be used in bowel and lung surgery, because staple lines may be more consistent and therefore less likely to leak blood, air or bowel contents.


While the use of staples for thoracic surgery has been widely accepted and regarded as a safe procedure, there are instances in which stapling is may be insufficient and unable to achieve complete closure of a wound, incision, or vessel. This may be particularly critical in certain thoracic procedures, particularly those involving pulmonary vasculature where the leakage of air and/or fluid contents can be life threatening.


In some procedures, a surgeon may rely on an electrosurgical device to seal or cauterize a vessel, wound, or incision by applying energy (e.g., electrical current, radiofrequency (RF), thermal energy, etc.) to the target tissue or vessel. Some current devices, particularly electrosurgical forceps, use mechanical action between opposing jaws to constrict tissue and further apply electrical energy to effect hemostasis by heating the tissue and blood vessels to coagulate, cauterize, cut and/or seal tissue. While current electrosurgical forceps allow for the sealing of tissue or vessels, such devices have shortcomings and are unable to be used in conjunction with sutures and/or staples. For example, some sutures and staples may be fragile (e.g., formed from bioabsorbable materials) and thus may be unable to withstand the compression forces and/or energy delivered via current electrosurgical forceps. Thus, the use of current electrosurgical forceps on a vessel or wound that includes a suture or staple may result in damage to the suture or staple, which may compromise the integrity of the seal and may further result in serious complications, such as an increase in wound severity as well as life-threating infection.


SUMMARY

An electrosurgical device can be delivered to a surgical site to provide sealing of vessels and/or vascular tissue. The device is useful for supplementing an initial closure of a vessel, wound, or incision via suturing or stapling. In particular, the device is configured to apply controlled compression and energy emission to the vessel, wound, or incision while maintaining the integrity of the suture or staple (i.e., without damaging the suture or staple). Accordingly, the electrosurgical device of the present disclosure provides for complete closure, thereby preventing leakage of air, contents, or fluid and subsequently preventing infection or life threatening complications.


The electrosurgical device is generally in the form of forceps and includes a probe acting as a handle and an end effector assembly positioned at a distal end of the probe. The end effector assembly includes opposing jaws configured to move relative to one another between open and closed positions upon corresponding input from the surgeon (i.e., via control from a trigger on the probe). Each jaw includes a deformable pad or cushion including an electrode array positioned along an exterior surface thereof and is configured to provide controlled compression upon a target tissue or vessel and subsequent delivery of radiofrequency (RF) energy for effectively sealing, cauterizing, coagulating, and/or desiccating the target tissue or vessel while maintaining the integrity of any suture(s) or staple(s).


In particular, the deformable cushion may generally include a nonconductive material that is flexible and configured to transition from a default shape (e.g., generally planar contact surface) to a deformed shape (e.g., one or more portions of contact surface become compressed) upon contact with a vessel or tissue and corresponding suture(s) or staple(s). The compression of the cushion allows for the electrode array to better conform to the contour of the target tissue or vessel on either side of a suture or staple, thereby improving contact and ablation/coagulation performance and enabling effective sealing around the suture or staple.


The electrode array on each cushion is configured to emit a non-ionizing radiation, such as RF energy, in a bipolar configuration for sealing, cauterizing, coagulating, and/or desiccating the vessel or tissue. The electrode array is composed of one or more conductive members (e.g., conductive wires) positioned along a length of the exterior surface of the cushion. In some embodiments, each of the plurality of conductive wires, or one or more sets of a combination of conductive wires, may be configured to independently receive an electrical current from an energy source (e.g., RF generator) and independently conduct energy, the energy including RF energy. This allows energy to be selectively delivered to a designated conductive wire or combination of conductive wires. This design also enables the ablation device to function in a bipolar mode because a first conductive wire (or combination of conductive wires) can deliver energy to the surrounding tissue through its electrical connection with an ablation generator while a second conductive wire (or combination of conductive wiress) can function as a ground or neutral conductive member.


The electrosurgical device is configured to deliver the RF energy via a virtual electrode arrangement, which includes distribution of a fluid along the exterior surface of each cushion and, upon activation of the electrode array, the fluid may carry, or otherwise promote, energy emitted from the electrode array to the surrounding tissue. In particular, each cushion includes one or more perforations in fluid communication with at least one lumen of the probe shaft configured receive a fluid, such as saline, from a fluid source. The one or more perforations allow the passage of the fluid to the exterior surface of the cushion. Upon transitioning the opposing jaws to the closed position, the corresponding cushions engage opposing sides of the target tissue or vessel, including one or more sutures or staples. The surgeon can apply force so as to compress the target tissue or vessel between the opposing cushions, wherein the exterior surface of each cushion generally conforms to the surface of the tissue or vessel and the suture(s) or staple(s) while maintaining the integrity of the suture or staple (i.e., without damaging the suture or staple). Due to the conforming nature of the cushions, each electrode array is able to come into contact with, and effectively seal, portions of the target tissue or vessel that are immediately adjacent to the suture(s) or staple(s), which are generally missed with current electrosurgical forceps.


The surgeon may then activate both the fluid delivery and eletrode array, each of which can be independently controlled via a controller. The fluid weeping through the perforations to the outer surface of the cushions is able to carry energy from electrode array, thereby creating a virtual electrode. Upon the fluid weeping through the perforations, a pool or thin film of fluid is formed on the exterior surface of the cushions and is configured to seal portions of the target tissue of vessel in contact therewith via the RF energy carried from the electrode array. Accordingly, the electrosurgical device of the present disclosure provides for complete closure of the target tissue or vessel, thereby preventing or reducing the risk of leakage of air, contents, or fluid and subsequently preventing infection or life threatening complications that may otherwise occur with simply a suture or staple closure.


The electrosurgical device of the present disclosure provides numerous advantages. In particular, the electrosurgical device is useful for supplementing an initial closure of a vessel, wound, or incision via suturing or stapling. The deformable cushion on each opposing jaw is configured to deform upon being compressed against the target tissue or vessel and the suture(s) or staple(s) such that the exterior surface of each cushion conforms and corresponds to the tissue or vessel surface and suture(s) or staple(s). The cushion is able to be compressed against the suture or staple without causing physical damage thereto or compromising the structural integrity of the suture or staple. Furthermore, due to the conforming nature of the cushions, each electrode array is able to come into contact with, and effectively seal, portions of the target tissue or vessel that are immediately adjacent to the suture(s) or staple(s), which are generally missed with current electrosurgical forceps as a result of the rigid, non-compliant sealing plates of such forceps. The virtual electrode arrangement of the present device further allows for a non-sticking surface during a sealing procedure, as the saline generally acts as a buffer between the tissue surface and the surface of the conductive wires. Furthermore, the virtual electrode provides for controlled emission of energy, including at least length of elapsed time and intensity, which, in turn, effectively controls the thermal energy released for sealing, which can be consistently maintained between 60° C. and 100° C. to prevent inadvertent damage to surrounding tissue.





BRIEF DESCRIPTION OF THE DRAWINGS

Features and advantages of the claimed subject matter will be apparent from the following detailed description of embodiments consistent therewith, which description should be considered with reference to the accompanying drawings, wherein:



FIGS. 1A and 1B are schematic illustrations of an electrosurgical system consistent with the present disclosure;



FIG. 2 is a perspective view of one embodiment of an electrosurgical device compatible with the system of FIG. 1A;



FIG. 3 is an enlarged view of the end effector assembly of the device of FIG. 2 in greater detail;



FIG. 4 is a plan view of an exterior contact surface of a deformable cushion and an electrode array positioned thereon;



FIGS. 5A and 5B are front views of the opposing jaws of the end effector assembly of the device of FIG. 2 in open and closed positions, respectively;



FIG. 6 is an enlarged view of another embodiment of an end effector assembly compatible with an electrosurgical device consistent with the present disclosure;



FIG. 7 is a plan view of one of the opposing jaws of the end effector assembly of FIG. 6 illustrating the deformable cushion and electrode array provided thereon;



FIG. 8 illustrates positioning of the end effector assembly of FIG. 2 for sealing of a stapled portion of lung tissue (lobe) in an open surgical environment;



FIG. 9 illustrates positioning of the end effector assembly of FIG. 6 for sealing of a stapled bronchial passageway via laparoscopic procedure; and



FIGS. 10A and 10B are side views of the end effector assembly of FIG. 2 in open and closed positions, respectively, relative to a portion of stapled lung tissue (FIG. 8), illustrating the cushions of the opposing jaws transitioning from a default shape (FIG. 10A) to a deformed shaped (FIG. 10B) and conforming to the tissue surface and in compliance with the staples.





For a thorough understanding of the present disclosure, reference should be made to the following detailed description, including the appended claims, in connection with the above-described drawings. Although the present disclosure is described in connection with exemplary embodiments, the disclosure is not intended to be limited to the specific forms set forth herein. It is understood that various omissions and substitutions of equivalents are contemplated as circumstances may suggest or render expedient.


DETAILED DESCRIPTION

By way of overview, the present disclosure is generally directed to an electrosurgical device can be delivered to a surgical site to provide sealing of vessels and/or vascular tissue. The device is useful for supplementing an initial closure of a vessel, wound, or incision via suturing or stapling. In particular, the device is configured to apply controlled compression and energy emission to the vessel, wound, or incision while maintaining the integrity of the suture or staple (i.e., without damaging the suture or staple). Accordingly, the electrosurgical device of the present disclosure provides for complete closure, thereby preventing leakage of air, contents, or fluid and subsequently preventing infection or life threatening complications.


The electrosurgical device is generally in the form of forceps and includes a probe acting as a handle and an end effector assembly positioned at a distal end of the probe. The end effector assembly includes opposing jaws configured to move relative to one another between open and closed positions upon corresponding input from the surgeon (i.e., via control from a trigger on the probe). Each jaw includes a deformable pad or cushion including an electrode array positioned along an exterior surface thereof and is configured to provide controlled compression upon a target tissue or vessel and subsequent delivery of radiofrequency (RF) energy for effectively sealing, cauterizing, coagulating, and/or desiccating the target tissue or vessel while maintaining the integrity of any suture(s) or staple(s). The electrosurgical device is configured to deliver radiofrequency (RF) energy via a virtual electrode arrangement, which includes distribution of a fluid along the exterior surface of each cushion and, upon activation of the electrode array, the fluid may carry, or otherwise promote, energy emitted from the electrode array to the surrounding tissue. In particular, each cushion includes one or more perforations in fluid communication with at least one lumen of the probe shaft configured receive a fluid, such as saline, from a fluid source. The one or more perforations allow the passage of the fluid to the exterior surface of the cushion. Upon transitioning the opposing jaws to the closed position, the corresponding cushions engage opposing sides of the target tissue or vessel, including one or more sutures or staples. The surgeon can apply force so as to compress the target tissue or vessel between the opposing cushions, wherein the exterior surface of each cushion generally conforms to the surface of the tissue or vessel and the suture(s) or staple(s) while maintaining the integrity of the suture or staple (i.e., without damaging the suture or staple). Due to the conforming nature of the cushions, each electrode array is able to come into contact with, and effectively seal, portions of the target tissue or vessel that are immediately adjacent to the suture(s) or staple(s), which are generally missed with current electrosurgical forceps.


The surgeon may then activate both the fluid delivery and eletrode array, each of which can be independently controlled via a controller. The fluid weeping through the perforations to the outer surface of the cushions is able to carry energy from electrode array, thereby creating a virtual electrode. Upon the fluid weeping through the perforations, a pool or thin film of fluid is formed on the exterior surface of the cushions and is configured to seal portions of the target tissue or vessel in contact therewith via the RF energy carried from the electrode array. Accordingly, the electrosurgical device of the present disclosure provides for complete closure of the target tissue or vessel, thereby preventing or reducing the risk of leakage of air, contents, or fluid and subsequently preventing infection or life threatening complications that may otherwise occur with simply a suture or staple closure.



FIGS. 1A and 1B are schematic illustrations of an electrosurgical system 10 for providing sealing of vessels and/or tissue of a patient 12. The electrosurgical system 10 generally includes an electrosurgical device 14, which includes a probe including an end effector assembly 16 and an elongated catheter shaft 17 to which the end effector assembly 16 is coupled. The catheter shaft 17 may generally include a nonconductive elongated member including at least a fluid delivery lumen, as will be described in greater detail herein. The electrosurgical device 14 may further be coupled to a device controller 18, a radiofrequency (RF) generator 20 over an electrical connection (electrical line 30 shown in FIG. 2), and an irrigation pump or drip 22 over a fluid connection (fluid line 34 shown in FIG. 2).


The device controller 18 may include hardware/software configured to provide a user with the ability to control electrical output to the electrosurgical device 14 in a manner so as to control energy output to a tissue or vessel intended to be sealed or that has initially undergone suturing or stapling. For example, as will be described in greater detail herein, the electrosurgical device may be configured to operate at least in a “bipolar mode” based on input from a user (e.g., surgeon, clinician, etc.) resulting in the emission of radiofrequency (RF) energy in a bipolar configuration. In some embodiments, the device 14 may be configured to operate in other modes, such as a “measurement mode”, in which data can be collected, such as certain measurements (e.g., temperature, conductivity (impedance), etc.) that can be taken and further used by the controller 18 so as to provide an estimation of the state of tissue during a sealing procedure, as will be described in greater detail herein. In some embodiments, the device controller 18 may be housed within the electrosurgical device 14. The RF generator 20 may also be connected to a separate return electrode 15 that is attached to the skin of the patient 12.


As will be described in greater detail herein, during a sealing procedure, the generator 20 may generally provide RF energy (e.g., electrical energy in the radiofrequency (RF) range (e.g., 350-800 kHz)) to an electrode array of the electro surgical device 14, as controlled by the device controller 18. At the same time, saline may also be provided to and released from the end effector assembly 16. In some embodiments, the RF energy travels through the blood and tissue of the patient 12 to a return electrode and, in the process, provides energy emission (e.g., sealing, cauterizing, coagulating and/or desiccating) to tissue adjacent to portions of the electrode array that have been activated.



FIG. 2 is a perspective view of electrosurgical device 14. As previously described, the electrosurgical device 14 includes a probe 17 including an elongated shaft configured as a handle and adapted for manual manipulation. Accordingly, as shown in FIG. 2, the probe 17 is in the form of a handle including a distal end 26 to which the end effector assembly 16 is coupled and a proximal end 28. The probe 17 may generally resemble forceps, for example, and thus may further include a trigger 40 allowing for a surgeon to control operation of the end effector assembly 16 (i.e., control opening and closing of opposing jaws 38a, 38b), as will be described in greater detail herein. As shown, the proximal end 28 of the probe 17 may be coupled to the generator 20 and the irrigation pump 22 via connection lines or fittings. For example, the probe 17 is coupled to the generator 20 via an electrical line 30 and coupled to the irrigation pump 22 via a fluid line 34. Each of the electrical line 30 and fluid line 34 may include an adaptor end 32 and 36 configured to couple the associated lines with a respective interface on the generator 20 and irrigation pump 22.


In some examples, the electrosurgical device 14 may further include a user interface (not shown) serving as the device controller 18 and in electrical communication with at least one of the generator 20, the irrigation pump 22, and the electrosurgical device 14. The user interface may include, for example, selectable buttons for providing an operator with one or more operating modes with respect to controlling the energy emission output of the device 14, as will be described in greater detail herein. For example, selectable buttons may allow a user to control electrical output to the electrosurgical device 14 in a manner so as to control the sealing, cauterizing, coagulating, and/or desiccating of portions of a tissue or vessel. Furthermore, in some embodiments, selectable buttons may provide an operator to control the delivery of fluid from the irrigation pump 22. vvAs shown, the end effector assembly 16 includes first and second jaws 38a, 38b generally opposing one another and configured to move relative to one another in response to user interaction with the trigger 40, as will be described in greater detail herein.



FIG. 3 is an enlarged view of the end effector assembly 16 in greater detail. As shown, each jaw 38a, 38b includes a deformable pad or cushion (hereinafter referred to as “cushion 42”) including an electrode array 44 positioned along an exterior surface thereof. Each cushion 42 is configured to provide controlled compression upon a target tissue or vessel and subsequent delivery of radiofrequency (RF) energy for effectively sealing, cauterizing, coagulating, and/or desiccating the target tissue or vessel while maintaining the integrity of any sutures or staples on the target tissue or vessel.


In particular, the deformable cushion may generally include a nonconductive material that is flexible and configured to transition from a default shape (e.g., generally planar contact surface) to a deformed shape (e.g., one or more portions of contact surface become compressed) upon contact with a vessel or tissue and corresponding sutures or staples (see FIGS. 9A and 9B). Accordingly, the nonconductive deformable cushion 42 may include an elastomeric or shape memory material. The compression of the cushion 42 allows for the electrode array 44 to better conform to the contour of the target tissue or vessel on either side of a suture or staple, thereby improving contact and ablation/coagulation performance and enabling effective sealing around the suture or staple.



FIG. 4 is a plan view of an exterior contact surface of a deformable cushion 42 and an electrode array 44 positioned thereon. The cushion 42 may have a length L in the range of 2-10 cm, and, in some embodiments, the length L may be 3-5 cm. The cushion 42 may have a width in the range of 0.5 mm to 3 mm, and, in some instances, is in the range of 0.7 to 1 mm. The electrode array 44 on each cushion 42 is configured to emit a non-ionizing radiation, such as RF energy, in a bipolar configuration for sealing, cauterizing, coagulating, and/or desiccating the vessel or tissue. The electrode array 44 is composed of one or more conductive members 46 (e.g., hereinafter referred to as “conductive wire(s) 46”) positioned along a length of the exterior surface of the cushion 42. In some embodiments, each of the plurality of conductive wires 46, or one or more sets of a combination of conductive wires 46, may be configured to independently receive an electrical current from an energy source (e.g., the RF generator 20) and independently conduct energy, the energy including RF energy. This allows energy to be selectively delivered to a designated conductive wire 46 or combination of conductive wires 46. This design also enables the electrosurgical device 14 to function in a bipolar mode because a first conductive wire (or combination of conductive wires) can deliver energy to the surrounding tissue through its electrical connection with an RF generator while a second conductive wire (or combination of conductive wires) can function as a ground or neutral conductive member. The conductive wires 46 can be formed of any suitable conductive material (e.g., a metal such as stainless steel, nitinol, or aluminum).


Since each conductive wire 46 in the electrode array 44 may be electrically independent, each conductive wire 46 can be connected in a fashion that allows for impedance measurements using bipolar impedance measurement circuits. For example, the conductive wires can be configured in such a fashion that tetrapolar or guarded tetrapolar electrode configurations can be used. For instance, one pair of conductive wires could function as the current driver and the current return, while another pair of conductive wires could function as a voltage measurement pair. Accordingly, a dispersive ground pad can function as current return and voltage references.


The electrosurgical device 14 is configured to deliver the RF energy via a virtual electrode arrangement, which includes distribution of a fluid along the exterior surface of each cushion 42 and, upon activation of the electrode array 44, the fluid may carry, or otherwise promote, energy emitted from the electrode array 44 to the surrounding tissue. In particular, each cushion 42 includes one or more perforations 48 in fluid communication with at least one lumen of the probe shaft configured receive a fluid, such as saline, from a fluid source (e.g., the irrigation drip 22). The one or more perforations 48 allow the passage of the fluid to the exterior surface of the cushion 42. As shown, each of the perforations 48 are generally aligned with an associated conductive wire 46. Accordingly, upon fluid weeping through the perforations 48, a pool or thin film of fluid is formed on the exterior surface of the cushion 42 and configured to ablate and/or coagulate via the electrical current conducted by the one or more conductive wires 46 of the electrode array 44, as described in greater detail herein.



FIGS. 5A and 5B are front views of the opposing jaws 38a, 38b of the end effector assembly 16 in open and closed positions, respectively. In some embodiments, both jaws 38a, 38b may move relative to one another and the probe shaft. In other embodiments, one of the jaws 38 may be fixed in position relative to the probe shaft while the other jaw 38 is configured to move relative to both the fixed jaw and the probe shaft. The opposing jaws 38a, 38b are configured to transition between open and closed positions in response to user input with the trigger 40, as shown in FIGS. 5A and 5B. For example, in the default open position, both jaws are spaced a distance D1 apart when the trigger 40 is not compressed. The distance D1 between the jaws 38a, 38b may generally be sufficient to receive a stapled portion of tissue or vessel there between. Once the target portion of tissue or vessel is positioned between the opposing jaws 38a, 38b when in the open position, the surgeon need only compress the trigger 40, which, in turn, results in movement of the jaws 38a, 38b towards one another and the target portion of tissue or vessel and be held or grasped in between the jaws 38a, 38b as the distance there between decreases until at least a distance D2 is reached, in which the target portion of tissue or vessel is compressed between the jaws 38a, 38b. Upon transitioning the jaws 38a, 38b to the closed position, sealing, cauterizing, coagulating, and/or desiccating of the target portion of tissue or vessel can occur, as will be described in greater detail herein.



FIG. 6 is an enlarged view of another embodiment of an end effector assembly 16a compatible with an electrosurgical device 14 consistent with the present disclosure. Unlike the end effector assembly 16 of FIGS. 2, 3, 4, and 5A-5B, the end effector assembly 16a is configured to laparoscopic procedures, in that the opposing jaws 38a, 38b include atraumatic tips and have a much more narrow profile. FIG. 7 is a plan view of one of the opposing jaws 38a of the end effector assembly 16a illustrating the deformable cushion and electrode array provided thereon.



FIG. 8 illustrates positioning of the end effector assembly 16 for sealing of a stapled portion of lung tissue (lobe) in an open surgical environment.



FIG. 9 illustrates positioning of the end effector assembly 16a for sealing of a stapled bronchial passageway via laparoscopic procedure. As shown, the end effector assembly 16a is configured to laparoscopic procedures, in that the opposing jaws 38a, 38b include atraumatic tips and have a much more narrow profile when compared to the configuration of the end effector assembly 16.



FIGS. 10A and 10B are side views of the end effector assembly 16 in open and closed positions, respectively, relative to a portion of stapled lung tissue (of FIG. 8), illustrating the cushions 42a, 42b of the corresponding opposing jaws 38a, 38b transitioning from a default shape (FIG. 10A) to a deformed shaped (FIG. 10B) and conforming to the tissue surface and in compliance with the staple.


As shown, once a surgeon positions the end effector assembly 16 relative to a target tissue to be sealed, the surgeon may then close the jaws 38a, 38b so as to clamp the target tissue there between. Upon transitioning the opposing jaws 38a, 38b to the closed position, the corresponding cushions 42a, 42b engage opposing sides of the target tissue, including one or more sutures or staples. The surgeon can apply force so as to compress the target tissue between the opposing cushions 38a, 38b, wherein the exterior surface of each cushion 42a, 42b generally conforms to the surface of the tissue and the staple while maintaining the integrity of the staple (i.e., without damaging the staple). Due to the conforming nature of the cushions 38a, 38b, each electrode array 44, specifically the conductive wires 46 is able to come into close contact with, and effectively seal, portions of the target tissue that are immediately adjacent to the staple, which are generally missed with current electrosurgical forceps. As shown, the end effector assembly 16 can generally accommodate an entire cross section of the lung tissue (lobe) to be received between the opposing jaws 38a, 38b.


The surgeon may then activate both the fluid delivery and electrode array 44, each of which can be independently controlled via controller 18, as previously described. The fluid weeping through the perforations 48, to the outer surface of the cushions 42a, 42b is able to carry energy from electrode array 44, thereby creating a virtual electrode. Upon the fluid weeping through the perforations 48, a pool or thin film of fluid is formed on the exterior surface of the cushions 38a, 38b and is configured to seal portions of the target tissue in contact therewith via the RF energy carried from the electrode array 44. Accordingly, the electrosurgical device 14 of the present disclosure provides for complete closure of the target tissue, thereby preventing or reducing the risk of leakage of air, contents, or fluid and subsequently preventing infection or life threatening complications that may otherwise occur with simply a suture or staple closure.


The electrosurgical device of the present disclosure provides numerous advantages. In particular, the electrosurgical device is useful for supplementing an initial closure of a vessel, wound, or incision via suturing or stapling. The deformable cushion on each opposing jaw is configured to deform upon being compressed against the target tissue or vessel and the suture(s) or staple(s) such that the exterior surface of each cushion conforms and corresponds to the tissue or vessel surface and suture(s) or staple(s). The cushion is able to be compressed against the suture or staple without causing physical damage thereto or compromising the structural integrity of the suture or staple. Furthermore, due to the conforming nature of the cushions, each electrode array is able to come into contact with, and effectively seal, portions of the target tissue or vessel that are immediately adjacent to the suture(s) or staple(s), which are generally missed with current electrosurgical forceps as a result of the rigid, non-compliant sealing plates of such forceps. The virtual electrode arrangement of the present device further allows for a non-sticking surface during a sealing procedure, as the saline generally acts as a buffer between the tissue surface and the surface of the conductive wires. Furthermore, the virtual electrode provides for controlled emission of energy, including at least length of elapsed time and intensity, which, in turn, effectively controls the thermal energy released for sealing, which can be consistently maintained between 60° C. and 100° C. to prevent inadvertent damage to surrounding tissue.


Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.


The terms and expressions which have been employed herein are used as terms of description and not of limitation, and there is no intention, in the use of such terms and expressions, of excluding any equivalents of the features shown and described (or portions thereof), and it is recognized that various modifications are possible within the scope of the claims. Accordingly, the claims are intended to cover all such equivalents.


Incorporation by Reference

References and citations to other documents, such as patents, patent applications, patent publications, journals, books, papers, web contents, have been made throughout this disclosure. All such documents are hereby incorporated herein by reference in their entirety for all purposes.


Equivalents

Various modifications and further embodiments are possible beyond what is shown and described herein. The subject matter herein contains information, exemplification, and guidance that can be adapted to create various other embodiments.

Claims
  • 1. A device for sealing a portion of tissue or vessels stapled with a staple, the device comprising: a handle including a proximal end and a distal end and at least one lumen extending therethrough; andan end effector assembly extending from the distal end of the handle, the end effector assembly comprises opposing jaws, at least one of which moves relative to the other, wherein each jaw comprises: a deformable cushion including a plurality of perforations in communication with the at least one lumen of the handle, the deformable cushion is configured to transition from a default state to a deformed state upon application of a compression force thereto and return to the default state upon removal of the compression force therefrom, wherein the plurality of perforations are configured to allow the passage of a fluid from the lumen of the handle to an exterior surface of the deformable cushion; andan electrode array comprising a plurality of conductive wires positioned on the exterior surface of the deformable cushion and configured to conduct energy for ablation or coagulation of the portion of the target stapled tissue or vessel that has the staple, wherein the conductive wires of the electrode array are configured to be maintained a close distance to portions of the target tissue or vessel on both sides of, and immediately adjacent to, the staple, but not over the staple.
  • 2. The device of claim 1, wherein the handle comprises a trigger configured to control movement of one or both jaws relative to one another between the open and closed positions.
  • 3. The device of claim 1, wherein, in the closed position, the opposing jaws are configured to compress the stapled portion of target tissue or vessel there between.
  • 4. The device of claim 3, wherein the exterior surface of the cushion of each jaw is configured to compress inwardly and conform to the surface of the staple and the surface of the target tissue or vessel, to thereby enable sealing of the target tissue or vessel without compromising the structural integrity of the staple or the target tissue or vessel.
  • 5. The device of claim 1, wherein the cushion of each jaw comprises a nonconductive material.
  • 6. The device of claim 1, wherein the cushion of each jaw comprises a shape memory material.
  • 7. The device of claim 1, wherein the cushion of each jaw comprises an elastomeric material.
  • 8. The device of claim 1, wherein the fluid is a conductive fluid.
  • 9. The device of claim 1, wherein an exterior surface of the cushion of each jaw comprises at least one portion of surface texturing to enhance fluid distribution.
  • 10. The device of claim 1, wherein delivery of fluid to the end effector assembly and through the plurality of perforations on the cushion of each jaw is controllable via a controller.
  • 11. The device of claim 1, wherein each opposing jaw comprises an atraumatic distal tip.
  • 12. The device of claim 1, wherein an exterior surface of the cushion of each jaw is configured to couple energy from the electrode array with the fluid to provide a non-stick surface when the energy is applied to the target tissue or vessel.
  • 13. The device of claim 1, wherein at least one of the plurality of conductive wires is configured to conduct energy to be carried by fluid passing through the plurality of perforations to the exterior surface of the deformable cushion to thereby provide a virtual electrode arrangement.
  • 14. The device of claim 13, wherein the energy is radiofrequency (RF) energy.
  • 15. The device of claim 13, wherein the fluid is conductive fluid.
  • 16. The device of claim 15, wherein the conductive fluid is saline.
  • 17. The device of claim 1, wherein each of the plurality of conductive wires is aligned with a separate respective one of the plurality of perforations.
  • 18. The device of claim 1, wherein each of the plurality of conductive wires, or one or more sets of a combination of conductive wires, is configured to independently receive an electrical current from an energy source and independently conduct energy.
  • 19. The device of claim 18, wherein the plurality of conductive wires are equidistantly spaced apart from one another along a length of the exterior surface of the deformable cushion.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of, and priority to, U.S. Provisional Application No. 62/419,227, filed Nov. 8, 2016, the content of which is hereby incorporated by reference herein in its entirety.

US Referenced Citations (206)
Number Name Date Kind
4699147 Chilson et al. Oct 1987 A
4976711 Parins et al. Dec 1990 A
4979948 Geddes et al. Dec 1990 A
5045056 Behl Sep 1991 A
5100423 Fearnot Mar 1992 A
5117828 Metzger et al. Jun 1992 A
5250074 Wilk Oct 1993 A
5334193 Nardella Aug 1994 A
5429605 Richling et al. Jul 1995 A
5471982 Edwards et al. Dec 1995 A
5472441 Edwards et al. Dec 1995 A
5486161 Lax et al. Jan 1996 A
5536267 Edwards et al. Jul 1996 A
5562720 Stern et al. Oct 1996 A
5657760 Ying et al. Aug 1997 A
5672153 Lax et al. Sep 1997 A
5672173 Gough et al. Sep 1997 A
5672174 Gough et al. Sep 1997 A
5683384 Gough et al. Nov 1997 A
5713942 Stern et al. Feb 1998 A
5728143 Gough et al. Mar 1998 A
5772590 Webster, Jr. Jun 1998 A
5782827 Gough et al. Jul 1998 A
5827276 LeVeen et al. Oct 1998 A
5840076 Swanson et al. Nov 1998 A
5846239 Swanson et al. Dec 1998 A
5855576 LeVeen et al. Jan 1999 A
5863290 Gough et al. Jan 1999 A
5868736 Swanson et al. Feb 1999 A
5868776 Wright Feb 1999 A
5871483 Jackson et al. Feb 1999 A
5888198 Eggers et al. Mar 1999 A
5891136 McGee et al. Apr 1999 A
5893847 Kordis Apr 1999 A
5913855 Gough et al. Jun 1999 A
5928229 Gough et al. Jul 1999 A
5935123 Edwards et al. Aug 1999 A
5961513 Swanson et al. Oct 1999 A
5980517 Gough Nov 1999 A
6009877 Edwards Jan 2000 A
6032077 Pomeranz Feb 2000 A
6036689 Tu et al. Mar 2000 A
6053913 Tu et al. Apr 2000 A
6053937 Edwards et al. Apr 2000 A
6063081 Mulier et al. May 2000 A
6071278 Panescu et al. Jun 2000 A
6071280 Edwards et al. Jun 2000 A
6099526 Whayne et al. Aug 2000 A
6112123 Kelleher et al. Aug 2000 A
6113598 Baker Sep 2000 A
6123718 Tu et al. Sep 2000 A
6142993 Whayne et al. Nov 2000 A
6221071 Sherry et al. Apr 2001 B1
6241666 Pomeranz et al. Jun 2001 B1
6251109 Hassett et al. Jun 2001 B1
6258087 Edwards et al. Jul 2001 B1
6309352 Oraevsky et al. Oct 2001 B1
6312408 Eggers et al. Nov 2001 B1
6312429 Burbank et al. Nov 2001 B1
6358248 Mulier et al. Mar 2002 B1
6379353 Nichols Apr 2002 B1
6409722 Hoey et al. Jun 2002 B1
6425877 Edwards Jul 2002 B1
6454766 Swanson et al. Sep 2002 B1
6491710 Satake Dec 2002 B2
6494902 Hoey et al. Dec 2002 B2
6503247 Swartz et al. Jan 2003 B2
6522930 Schaer et al. Feb 2003 B1
6537248 Mulier et al. Mar 2003 B2
6537272 Christopherson et al. Mar 2003 B2
6544262 Fleischman Apr 2003 B2
6551310 Ganz et al. Apr 2003 B1
6585732 Mulier et al. Jul 2003 B2
6623481 Garbagnati et al. Sep 2003 B1
6638275 McGaffigan et al. Oct 2003 B1
6648883 Francischelli et al. Nov 2003 B2
6663622 Foley et al. Dec 2003 B1
6692466 Chow et al. Feb 2004 B1
6736810 Hoey et al. May 2004 B2
6736811 Panescu et al. May 2004 B2
6743226 Cosman et al. Jun 2004 B2
6764487 Mulier et al. Jul 2004 B2
6770072 Truckai Aug 2004 B1
6780183 Jimenez, Jr. et al. Aug 2004 B2
6805131 Kordis Oct 2004 B2
6826421 Beatty et al. Nov 2004 B1
6849073 Hoey et al. Feb 2005 B2
6872206 Edwards et al. Mar 2005 B2
6878149 Gatto Apr 2005 B2
6955641 Lubock Oct 2005 B2
6978788 Klimberg et al. Dec 2005 B2
6984232 Vanney et al. Jan 2006 B2
7104989 Skarda Sep 2006 B2
7150745 Stern et al. Dec 2006 B2
7156845 Mulier et al. Jan 2007 B2
7169144 Hoey et al. Jan 2007 B2
7247155 Hoey et al. Jul 2007 B2
7276061 Schaer et al. Oct 2007 B2
7306593 Keidar et al. Dec 2007 B2
7326208 Vanney et al. Feb 2008 B2
7344535 Stern et al. Mar 2008 B2
7364579 Mulier et al. Apr 2008 B2
7367972 Francischelli et al. May 2008 B2
7371231 Rioux et al. May 2008 B2
7399299 Daniel et al. Jul 2008 B2
7416552 Paul et al. Aug 2008 B2
7419489 Vanney et al. Sep 2008 B2
7556628 Utley et al. Jul 2009 B2
7632268 Edwards et al. Dec 2009 B2
7717909 Strul et al. May 2010 B2
7769432 Klimberg et al. Aug 2010 B2
7776034 Kampa Aug 2010 B2
7803156 Eder Sep 2010 B2
7828793 Thompson et al. Nov 2010 B2
7862498 Nguyen et al. Jan 2011 B2
7879030 Paul et al. Feb 2011 B2
7942873 Kwan et al. May 2011 B2
7959628 Schaer et al. Jun 2011 B2
7959631 DiCarlo Jun 2011 B2
8034022 Boatman Oct 2011 B2
8043289 Behl et al. Oct 2011 B2
8048069 Skwarek et al. Nov 2011 B2
8114071 Woloszko et al. Feb 2012 B2
8224416 de la Rama et al. Jul 2012 B2
8303584 Burdio Pinilla et al. Nov 2012 B2
8388573 Cox Mar 2013 B1
8398624 Rioux et al. Mar 2013 B2
8409193 Young et al. Apr 2013 B2
8444638 Woloszko et al. May 2013 B2
8465484 Davalos et al. Jun 2013 B2
8465486 Danek et al. Jun 2013 B2
8588886 de la Rama et al. Nov 2013 B2
8591461 Boatman Nov 2013 B2
8617158 Garabedian et al. Dec 2013 B2
8647339 Satake Feb 2014 B2
8657814 Werneth et al. Feb 2014 B2
8734439 Gough et al. May 2014 B2
8814855 DiCarlo et al. Aug 2014 B2
8834461 Werneth et al. Sep 2014 B2
8979841 Kunis et al. Mar 2015 B2
9078665 Moss et al. Jul 2015 B2
9131980 Bloom Sep 2015 B2
9839472 Rioux et al. Dec 2017 B2
9848936 Rioux et al. Dec 2017 B2
9855098 Rioux Jan 2018 B2
20010031941 Edwards et al. Oct 2001 A1
20020026186 Woloszko et al. Feb 2002 A1
20020062123 McClurken et al. May 2002 A1
20020087208 Koblish et al. Jul 2002 A1
20020095152 Ciarrocca et al. Jul 2002 A1
20020115992 Utley et al. Aug 2002 A1
20020120267 Phan Aug 2002 A1
20030009166 Moutafis et al. Jan 2003 A1
20030036680 Black Feb 2003 A1
20030130711 Pearson et al. Jul 2003 A1
20030158547 Phan Aug 2003 A1
20030225403 Woloszko et al. Dec 2003 A1
20040087936 Stern et al. May 2004 A1
20040092960 Abrams et al. May 2004 A1
20050154386 West et al. Jul 2005 A1
20060212032 Daniel et al. Sep 2006 A1
20060259027 Kwan et al. Nov 2006 A1
20070083195 Werneth et al. Apr 2007 A1
20080004534 Gelbart et al. Jan 2008 A1
20080103494 Rioux et al. May 2008 A1
20090171340 Young Jul 2009 A1
20090248021 McKenna Oct 2009 A1
20090292177 Eggers et al. Nov 2009 A1
20090299355 Bencini et al. Dec 2009 A1
20100114087 Edwards et al. May 2010 A1
20100256629 Wylie et al. Oct 2010 A1
20110172485 Lubock Jul 2011 A1
20110257646 Utley et al. Oct 2011 A1
20120029510 Haverkost Feb 2012 A1
20120059437 Shalev Mar 2012 A1
20120109250 Cates et al. May 2012 A1
20120172680 Gelfand et al. Jul 2012 A1
20130085493 Bloom et al. Apr 2013 A1
20130158536 Bloom Jun 2013 A1
20130172870 Germain et al. Jul 2013 A1
20130184702 Neal, II et al. Jul 2013 A1
20130253506 Rioux et al. Sep 2013 A1
20140018788 Engelman et al. Jan 2014 A1
20140018794 Anderson et al. Jan 2014 A1
20140031810 Mahvi et al. Jan 2014 A1
20140058376 Horn et al. Feb 2014 A1
20140221998 Latterell Aug 2014 A1
20140276731 Voegele et al. Sep 2014 A1
20140276748 Ku et al. Sep 2014 A1
20150018817 Willard Jan 2015 A1
20150141982 Lee May 2015 A1
20160113707 Sahakian et al. Apr 2016 A1
20160113708 Moss et al. Apr 2016 A1
20160184008 Papaioannou et al. Jun 2016 A1
20160317221 Rioux Nov 2016 A1
20170000559 Rioux et al. Jan 2017 A1
20170027633 Wham et al. Feb 2017 A1
20170119454 Rioux et al. May 2017 A1
20170215947 Rioux et al. Aug 2017 A1
20170215951 Wang et al. Aug 2017 A1
20170252092 Rioux et al. Sep 2017 A1
20170281267 Rioux et al. Oct 2017 A1
20170281271 Rioux Oct 2017 A1
20180014880 Rioux et al. Jan 2018 A1
20180078305 Rioux et al. Mar 2018 A1
20180104004 Rioux et al. Apr 2018 A1
Foreign Referenced Citations (16)
Number Date Country
2610858 Apr 2004 CN
104546124 Apr 2015 CN
102010032932 Feb 2012 DE
0777445 Jun 1999 EP
2942023 Feb 2016 EP
3009735 Feb 2000 JP
9510326 Apr 1995 WO
9942047 Aug 1999 WO
0051683 Sep 2000 WO
2007-103986 Sep 2007 WO
2012015722 Feb 2012 WO
2014022379 Feb 2014 WO
2014189887 Nov 2014 WO
2015142674 Sep 2015 WO
2015200518 Dec 2015 WO
2016181318 Nov 2016 WO
Non-Patent Literature Citations (21)
Entry
Non-Final Office Action dated May 7, 2018 for U.S. Appl. No. 15/142,616 (13 Pages).
International Search Report and Written Opinion of the International Searching Authority dated Aug. 26, 2018 for International Application No. PCT/US2017/059850 (10 Pages).
Notice of Allowance dated Jul. 24, 2018 for U.S. Appl. No. 15/784,778 (12 Pages).
International Search Report and Written Opinion dated Jun. 6, 2018 for International Application No. PCT/US2018/019151 (17 Pages).
International Search Report and Written Opinion of the International Searching Authority dated Sep. 16, 2018 or International Application No. PCT/US2018/036268 (11 Pages).
International Search Report and Written Opinion of the Interational Searching Authority dated Feb. 27, 2018 for International Application No. PCT/US2017/056754 (11 Pages).
International Search Report and Written Opinion of the International Searching Authority dated Nov. 1, 2018 for International Application No. PCT/US2018/043654 (10 Pages).
International Search Report and Written Opinion of the International Searching Authority dated Nov. 15, 2018 for International Application PCT/US2018/043658 (15 Pages).
“Aquamantys System” Product Brochure, Medtronic, 2014 (12 Pages).
“Starburst Talon” Specifications Brochure, Angiodynamics, 2013 (2 Pages).
Extended European Search Report dated Jun. 10, 2016 for European Application No. 13825361.2 (13 Pages).
International Search Report and Written Opinion of the International Searching Authority dated Aug. 22, 2016 for International Application No. PCT/US2016/030081 (11 Pages).
International Search Report and Written Opinion of the International Searching Authority dated Aug. 5, 2015 for International Application No. PCT/US2015/020596 (13 Pages).
International Search Report and Written Opinion of the International Searching Authority dated Feb. 2, 2017 for International Application No. PCT/US2016/059345 (10 Pages).
International Search Report and Written Opinion of the International Searching Authority dated Jun. 11, 2017 for ntemational Application No. PCT/US2017/019398 (27 Pages).
International Search Report and Written Opinion of the International Searching Authority dated May 16, 2017 for International Application No. PCT/US2017/015582 (11 pages).
International Search Report and Written Opinion of the International Searching Authority dated May 16, 2017 for International Application No. PCT/US2017/015584 (11 pages).
International Search Report and Written Opinion of the International Searching Authority dated Nov. 29, 2013 or International Application No. PCT/US2013/052703 (11 Pages).
International Search Report and Written Opinion of the International Searching Authority dated Oct. 19, 2017 for International Application No. PCT/US2017/041501 (63 Pages).
Medtronic, “Aquamantys Bipolar Sealers.” Electrosurgical Products, Jun. 2017. Retrieved Jul. 21, 2017. <http://www.medtronic.com/us-en/healthcare-professionals/products/general-surgery/electrosurgical/aquamantys-bipolar-sealers.html> (11 Pages).
Extended European Search Report, dated Feb. 28, 2020, Application No. 17895758.8, 8 pages.
Related Publications (1)
Number Date Country
20180125570 A1 May 2018 US
Provisional Applications (1)
Number Date Country
62419227 Nov 2016 US